Showing results (11-20 of 494) with videos related to
Sort By:
Pageof 50
Diabetes, Obesity & Metabolism|April 7, 2020
Emerging opportunities to harness real world data: An introduction to data sources, concepts, and applicationsColin P O'Leary, Matthew A CavenderAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 27, 2010
Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitusMatthew A Cavender, A Michael LincoffLancet (London, England)|August 19, 2014
Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trialsMatthew A Cavender, Marc S SabatineNature Reviews. Cardiology|August 28, 2012
Stent choice and the hidden consequences of cost savingsMatthew A Cavender, Stephen G EllisHeart Failure Clinics|September 2, 2019
Hypertension Treatment in Diabetes: Focus on Heart Failure PreventionHannah F Bensimhon, Matthew A CavenderInterventional Cardiology Clinics|March 6, 2019
Periprocedural Myocardial Infarction in Contemporary PracticeDavid W Lee, Matthew A CavenderJournal of the American College of Cardiology|March 20, 2003
Troponin: an important prognostic marker and risk-stratification tool in non-ST-segment elevation acute coronary syndromesL Kristin Newby, Britta U Goldmann, E Magnus OhmanCirculation. Cardiovascular Interventions|February 5, 2021
Therapeutic Approaches for the No-Option Refractory Angina PatientThomas J Povsic, Timothy D Henry, E Magnus OhmanClinical Case Reports|October 31, 2014
Retrograde approach to coronary chronic total occlusion via an occluded saphenous bypass graft: a case reportWesam A Alhejily, David F Kong, E Magnus OhmanThe American Heart Hospital Journal|November 13, 2004
Facilitated percutaneous coronary intervention in acute myocardial infarction: attractive concept but difficult to prove!Robert V Kelly, Mauricio G Cohen, E Magnus OhmanPageof 50